A Pioneer In Animal Rehab EducationApril 17, 2009 Six years ago, Janet Van Dyke, DVM, packed all her surgical tools into a big blue Rubbermaid plastic tub. Best to keep them handy, she thought. This new idea about starting a canine physical rehabilitation business might be the biggest stumble of her career. “I gave myself six months’ sabbatical to try and make this thing happen,” she says. She needn’t have worried. Today the Canine Rehabilitation Institute Dr. Van Dyke founded in Wellington, Fla., is a thriving business with a second facility opening this spring on the campus of Colorado State University in Fort Collins. The institute has certificated about 100 students, attracted an impressive roster of physical therapists and veterinarians to teach its courses and become a model provider of animal rehabilitation certification–even as the veterinary community works to create a governing body to oversee the certification of this emerging specialty. And if there’s one sure sign that a trend is sticking, it’s the arrival of healthy competition in the form of similar certification programs, which Van Dyke welcomes. “A little competition forces us to stay on our toes and do the best that we can do,” Van Dyke says. Competition has …
SPONSORED CONTENTHow can you help new pet owners keep their new dogs protected?See why new dog owners and their pets can benefit from simple triple protection in one monthly chew. + See the Difference
Financial Newswire 04-30-2008April 17, 2009VCA Antech Inc. Los Angeles-based VCA Antech Inc. recently reported that its animal hospital revenue for the first quarter ending March 31 was $226.1 million, compared to revenue of $187.2 million in the year-ago period. The 20.8 percent increase was driven by acquisitions and same-store revenue growth of 1.9 percent. The company reported laboratory revenue of $76.7 million for the first quarter, compared to $73.6 million in the year-ago period. Medical technology revenue was $13.8 million for the first quarter, compared to $11.2 million in the year-ago period. Overall, VCA Antech reported net income of $31.2 million on revenue of $307.8 million for the first quarter, compared to net income of $28.3 million on revenue of $265.1 million in the year-ago period. The company’s 2008 financial guidance includes revenue from $1.3 billion to $1.33 billion. Eli Lilly and Company Eli Lilly and Co.’s animal health division reported U.S. sales of $107.6 million for its first quarter ended March 31, up 16 percent compared to the year-ago period. Worldwide sales were $235.3 million, an increase of 9 percent compared to the year-ago period. Sales outside the United States grew 4 percent to $127.7 million. …
Neogen; PetmedApril 17, 2009Neogen Corp. Neogen Reports Record Quarter Neogen Corp.’s Animal Safety Division reported revenue of $15.8 million for the second quarter ended Nov. 30, up 24 percent from $12.7 million in the year-ago period. Year to date, the division reported revenue of $29.1 million, up 33 percent. Sales of veterinary biologics increased more than 60 percent in the quarter as the company responded to suspected equine botulism outbreaks in at least four U.S. states. Sales of Kane products, including veterinary obstetrical gloves, bovine hoofcare and surgical supplies, rose about 20 percent in the quarter compared to the prior year. Neogen’s line of veterinary supplements primarily for dogs and cats saw a 26 percent increase in sales. Overall, the Lansing, Mich.-based company reported net income of $3.9 million on revenue of $31.2 million in the second quarter, compared to net income of $3.3 million on revenue of $27.2 million in the year-ago period. Neogen said this was the best quarterly performance in its 26-year history. Year to date, Neogen reported net income of $7.6 million on revenue of $60.0 million, compared to $6.3 million and $50.1 million, respectively, in the year-ago period. …
Henry Schein, MWI, Hill'sApril 17, 2009Henry Schein to Cut 300 Jobs In an effort to reduce costs in the current economic environment, Henry Schein of Melville, N.Y., will eliminate about 300 positions from its operations around the world, or about 2.5 percent of its workforce. The company will also close several smaller facilities. “Given the recent changes in the economic climate, we expect that the markets Henry Schein serves will continue to grow, but at somewhat slower rates during these challenging economic times,” said Stanley Bergman, chairman and chief executive officer of the company. “While we remain confident in our ability to achieve our financial goals, we are taking these actions in light of our view that sales growth for 2009 may moderate somewhat from what we have experienced over the past several years. “This is a difficult decision, but by taking these steps to reduce costs, Henry Schein will remain well positioned to help our customers operate more successful practices and deliver high quality of care to patients.” Henry Schein reported net income of $68.43 million on revenue of $1.65 billion for its third quarter ended Sept. 27, compared to net income of $59.57 million on revenue of $1.51 billion. …
Pet DRx Corp.April 17, 2009 Pet DRx Corp. of Brentwood, Tenn., recently reported net loss of $5.24 million on revenue of $17.92 million for its second quarter ended June 30, 2008 compared to net loss of $3.27 million on revenue of $17.73 million in the year-ago period. “We are pleased to have grown same-store revenue in this challenging economic environment,” said Steven Johnson, president and chief operating officer. “We acquired an additional facility in July which further strengthens our presence in the Coachella Valley in California. “We continue to focus on optimizing the productivity and efficiency of our current facilities in California, and remain confident that our strategy of building ‘hub-and-spoke’ networks in high volume markets will provide customers with the best possible service. “We also delivered on our goal of moving the trading of Pet DRx from the OTC Bulletin Board to the Nasdaq, which has increased our visibility in the financial community.” Year to date, the company reported net loss of $8.27 million on revenue of $35.76 million, compared to net loss of $5.8 million on revenue of $28.4 million. Pet DRx has temporarily suspended its financial guidance. It expects to resume guidance following the completion of …
VCA Antech Inc. - 04-25-2008April 17, 2009 Los Angeles-based VCA Antech Inc. recently reported that its animal hospital revenue for the first quarter ending March 31 was $226.1 million, compared to revenue of $187.2 million in the year-ago period. The 20.8 percent increase was driven by acquisitions and same-store revenue growth of 1.9 percent. The company reported laboratory revenue of $76.7 million for the first quarter, compared to $73.6 million in the year-ago period. Medical technology revenue was $13.8 million for the first quarter, compared to $11.2 million in the year-ago period. Overall, VCA Antech reported net income of $31.2 million on revenue of $307.8 million for the first quarter, compared to net income of $28.3 million on revenue of $265.1 million in the year-ago period. The company’s 2008 financial guidance includes revenue from $1.3 billion to $1.33 billion. <HOME>
MWI, VCA, WebsterApril 17, 2009MWI Reports 14% Revenue Growth MWI Veterinary Supply Inc. of Meridian, Idaho, reported net income of $5.9 million on revenue of $231.8 million in the first quarter ended Dec. 31. That compares to net income of $4.7 million on revenue of $203.4 million in the year-ago period. “While the environment is more challenging, the MWI team again delivered great operating results in the December quarter,” said Jim Clearly, president and chief executive officer. “We had 14 percent growth in revenue, 26 percent growth in net income, 42 percent growth in Internet sales, and we finished the quarter with excellent liquidity and no borrowings on our $70 million credit line.” MWI reaffirms its estimates for the fiscal year ending Sept. 30. The company expects revenue of $900 million to $950 million, which represents growth of 8 to 14 percent. VCA Antech Sees 9.4% Rise in Animal Hospital Revenue VCA Antech Inc.’s Animal Hospital Division reported revenue of $229 million in the fourth quarter ended Dec. 31, compared to $209.3 million in the year-ago period. The 9.4 percent increase was driven by acquisitions. During the fourth quarter, the company acquired …
Heska, Procter & Gamble, Nestle Purina - 08-13-2008April 17, 2009Heska Corp. Heska Corp.’s companion animal health division recently reported revenue of $17.32 million for its second quarter ended June 30, compared to revenue of $16.24 million in the year-ago period. Year to date, the division reported revenue of $34.68 million, compared to revenue of $33.23 million in the year-ago period. Overall, Heska reported net income of $666,000 on revenue of $22.62 million for its second quarter, compared to net income of $1.03 million on revenue of $20.09 million in the year-ago period. Year to date, the company reported net income of $440,000 on revenue of $44.53 million, compared to net income of $3.43 million on revenue of $42.8 million in the year-ago period. “We posted a solid second quarter result, with revenue from our new chemistry instrument—the Heska Dri-Chem 4000 Veterinary Clinical Chemistry Analyzer by Fujifilm—representing a key factor in our Core Companion Animal Health segment product revenue growth,” said Robert Grieve, Heska’s chairman and chief executive officer. “Beginning in 2008 we are reporting our domestic net operating loss usage and other deferred tax items as income tax expense. This presents a difficult comparison as we did no report these items as income …
VCA Antech Inc.April 17, 2009 VCA Antech Inc.’s animal hospital division reported revenue of $209.3 million for its fourth quarter ended Dec. 31, compared to revenue of $171.9 million in the year-ago period. Year to date, the division reported revenue of $844.3 million for its fourth quarter, compared to revenue of $712 million in the year-ago period. Animal hospital same-store revenue for the fourth quarter grew 2.5 percent. Year to date, animal hospital same-store revenue grew 5.2 percent. The laboratory division reported revenue of $68.6 million for its fourth quarter, compared to revenue of $63.3 million in the year-ago period. Year to date, the division reported revenue of $295.7 million, compared to revenue of $258.3 million in the year-ago period. The medical technology division reported revenue of $13.9 million for its fourth quarter, compared to revenue of $14 million in the year-ago period. Year to date, the division reported revenue of $46.8 million, compared to revenue of $39.3 million in the year-ago period. Overall, VCA Antech reported net income of $24.6 million on revenue of $284.2 million for its fourth quarter, compared to net income of $19.3 million on revenue of $242.4 million in the year-ago period. Year to …
Neogen’s Animal Safety Division Sees 45% IncreaseApril 17, 2009 Neogen Corp.’s animal safety division recently reported revenue of $13.26 million for its first quarter ended Aug. 31, compared to revenue of $9.15 million in the year-ago period, representing a 45 percent increase. The increase included growth in products sold to veterinarians through ethical market channels, growth in products sold to large food animal producers and processors and a continued increase in sales of diagnostic products. The company also noted the resurgence of same-store sales growth within the division, especially within its Hacco subsidiary, which specializes in rodenticides and other bait formulations. Neogen’s food safety division reported revenue of $15.55 million for its first quarter, compared to revenue of $13.76 million in the year-ago period, representing a 13 percent increase. The increase was led by sales of diagnostic tests for food allergens—a 48 percent increase—driven by new customers and a number of high-profile food recalls related to food allergens. International sales accounted for 42 percent of total first quarter revenue and were helped by the June formation of Neogen’s new subsidiary in Mexico to enhance distribution of products in that country, and Central America. The company’s Scotland-based Neogen Europe subsidiary also continued …
